Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer

NCT00405366 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators